AzTrials
AzTrials

Gender Dysphoria Vaginoplasty SexualityGGAS-SEXNCT05292820

Sexual Function of Trans Women After Vaginoplasty

An observational study of Gender Dysphoria Vaginoplasty Sexuality, run by Hospices Civils de Lyon at 3 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Genital feminine affirming surgery may be an important step for transgender women. Vaginoplasty consists in the creation of external female genitalia and an operational vaginal cavity, and thus responds to major functional and aesthetic issues. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Gender Dysphoria Vaginoplasty Sexuality
What is being tested?
Validated and non-validated questionnaire for exploration of sexuality and satisfaction after surgical procedure
How many people
158 participants
Where
3 sitesFrance
Study dates
16 Nov 2021to 5 Jan 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Study population: Transwomen who underwent vaginoplasty or revision in Lyon, Lille, Limoges between January 2007 and December 2019

Who may be able to join

  • > 18 years old
  • Underwent vaginoplasty or revision in Lyon South Hospital, Lille University Hospital, Limoges University Hospital, between January 2007 and December 2019
  • Penile inversion vaginoplasty with scrotal skin graft

Who cannot join

  • < 18 years old
  • Vaginoplasty other than scrotal skin graft : intestinal segment or peritoneal flap

Trial locations and contacts

3 sites in 1 country.

France3 sites
  • Lille University Hospital

    Lille, 59000

  • Limoges University Hospital

    Limoges, 87000

  • Lyon South Hospital

    Lyon, 69000

Other trials in France

About this study

Official title: Exploring Sexual Function and Satisfaction of Trans Women After Vaginoplasty: Results of a Multicentric Survey

Genital feminine affirming surgery may be an important step for transgender women. Vaginoplasty consists in the creation of external female genitalia and an operational vaginal cavity, and thus responds to major functional and aesthetic issues.

Different techniques are available: inversion of penile skin flap for creation of the vulva. The vaginal cavity may come from scrotal skin graft, sigmoid segment, small intestine, or peritoneal flap.

Read more

Vaginoplasty has a major place in the the transgender woman pathway, but the specific evaluation of long-term sexuality has not been explored so far.

Multicentric (Lyon, FR - Lille, FR - Limoges, FR), prospective, observational study Patients who underwent vaginoplasty or revision vaginoplasty.

Main objective:

To assess sexuality after sex reassignment surgery in transgender women.

Being tested
Validated and non-validated questionnaire for exploration of sexuality and satisfaction after surgical procedure
Keywords
Genital gender affirming surgery, Gender dysphoria, Transwomen, Vaginoplasty, Sexuality, Satisfaction
Medical subject headings
Gender Dysphoria, Sexuality, Personal Satisfaction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Validated and non-validated questionnaire for exploration of sexuality and satisfaction after surgical procedureOther

    Validated questionnaire : Female Sexual Function Index (FSFI), Female Genital Self-Imaging Scale (FGSIS), Body Image Scale (BIS), Non-validated questionnaire exploring post-surgery satisfaction, self-esteem scale, sexology.

Study groups in NCT05292820
Study groupRoleWhat they receive
Transwomen vaginoplastyTransgender women who underwent vaginoplasty
Receives: Other: Validated and non-validated questionnaire for exploration of sexuality and satisfaction after surgical procedure

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. evaluation of FSFI : Female Sexual Function Index

    specific questionnaire scale

    Measured: At inclusion

  2. evaluation of FGSIS : Female Genital Self Imaging Scale

    specific questionnaire scale

    Measured: At inclusion

  3. evaluation of BIS : Body Image Scale

    specific questionnaire scale

    Measured: At inclusion

  4. evaluation of Rosenberg Self-esteem scale

    specific questionnaire scale

    Measured: At inclusion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Mar 2022
  2. Study start16 Nov 2021
  3. Primary completion5 Jan 2022
  4. Study completion5 Jan 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
158 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05292820
Sponsor's protocol ID
69HCL21_0746
Acronym
GGAS-SEX
Status last verified
Feb 2023
First submitted
14 Mar 2022
Last updated
10 Feb 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Gender Dysphoria Vaginoplasty Sexuality, run by Hospices Civils de Lyon at 3 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

evaluation of FSFI : Female Sexual Function Index (time frame: At inclusion). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Feb 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in